Popular Articles

Provectus Pharmaceuticals To Offer Compassionate Use Of PV-10 For Non-Visceral Indications In Cancer Patients
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun a compassionate use program for PV-10 and has made the agent, which is in development as a therapeutic agent for a broad spectrum of cancers, available for select cancer patients.

Circumcising Men With HIV Did Not Protect Women, Trial Stopped Early
Early results of a trial in Uganda showed that circumcising men with HIV did not protect their female partners, and as circumcision does not
News of the day
New Study May Help Understand How Alzheimer's Robs Sufferers Of Episodic Memory
Memory loss is love"s great thief. Those who suffer aren"t just the ones who can"t remember - family, friends and loved ones agonize over how to react when the disorder begins its often inexorable progress.
Cardiovascular

IOM Vitamin D And Calcium Workshop On Aug. 4

As part of its study of how much vitamin D and calcium people need, a committee convened by the Institute of Medicine will hold a public workshop to gather insights and data from experts on Tuesday, Aug. 4. Among the workshop"s presentations will be a discussion of a recent vitamin D and calcium report released by the Agency for Healthcare Research and Quality, which can be found at http://www.ahrq.gov/clinic/tp/vitadcaltp.htm. A workshop agenda with a list of presentations is available at http://www.iom.edu/?id=68400. The workshop will run from 8 a.m. through 5 p.m. in Room 100 of the National Academies" Keck Center, 500 Fifth St., N.W., Washington, D.C. Due to space limitations, advance registration is required. Christine Stencel National Academy of Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):